| (Values in U.S. Thousands) | Jun, 2026 | Jun, 2026 | Jun, 2026 | Jun, 2026 | Jun, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Pacgen Life Science Corp (PBS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Pacgen Life Science Corp is a Canada based life science company. It is focused on building a global commercial platform to market and distribute consumer health products like Babycare, acne care, cosmetics, personal care and others. The company markets the products under the P113, DermaMed, DermaSoleil and Deserving Health tradename, in two reportable market segments including oral care and skin care. P113 is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in human saliva. The group operations are principally located in Canada.